1-3 of 3
Tao Chen
Close
Sort by
Journal Articles

MM-SZ01 Study: A Prospective, Randomized, Controlled, Multicenter Phase III Clinical Study Which Compared Polyethylene Glycol Liposomal Doxorubicin Versus Doxorubicin Combined with Bortezomib and Dexamethasone (PDD regimen vs PAD regimen) in the Treatment of Newly Diagnosed Multiple Myeloma in China

Qingqing Wang, Depei Wu, Chengcheng Fu, Shuang Yan, ChengHao Jin, Xuzhang Lu, Tao Chen, Fei Li, Zhongjun Xia, Bingzhong Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 12614–12615.
https://doi.org/10.1182/blood-2022-159065
Published: 2022
Journal Articles

Single-Cell Multi-Omics Analysis Reveals the Role of CX3CR1 + GNLY + CD8 + T Cells in Improving Survival of Patients with Relapse/Refractory Hematologic Malignancies after Haplo+Cord HSCT

Hua Li, Zheyang Zhang, Ming Zhu, Xiaofan Li, Tao Chen, Yuanzhong Chen, Jialiang Huang, Nainong Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 7349.
https://doi.org/10.1182/blood-2022-157757
Published: 2022
Journal Articles

Interim and Post-Treatment Positron Emission Tomography-Computed Tomography Scan Status Is Highly Predictive Of Outcome In Diffuse Large Cell Lymphoma Patients Treated With R-CHOP21

Honghui Huang, Fei Xiao, Fangyuan Chen, Xiaofeng Han, Lu Zhong, Hua Zhong, Lan Xu, Jianyi Zhu, Beiwen Ni, Jia Liu, Tao Chen
Journal: Blood
Blood (2013) 122 (21): 4294.
https://doi.org/10.1182/blood.V122.21.4294.4294
Published: 2013